Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -257.92x is 172% below its 3-year average of -94.79x, near the high end of its 3-year range (-736.13x–-55.89x).
As of the fiscal period ended Friday, June 30, 2023. 115.63% below its 12-month average of -119.61x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2023 (2023-06-30): -257.92x.
INTEREST COVERAGE RATIO
-257.92x
INTEREST COVERAGE RATIO AVG TTM
-119.61x
INTEREST COVERAGE RATIO AVG 3Y
-94.79x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-115.63%
CURRENT VS 3Y AVG
-172.08%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 526 covered companies
CURRENT VS SECTOR MEDIAN
-3945.79%
vs the sector median at left
Century Therapeutics, Inc.
Market Cap
$249.88M
Interest Coverage Ratio
-257.92x
TTM Avg
-119.61x
3Y Avg
-94.79x
5Y Avg
N/A
Market Cap
$244.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$246.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.54M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$248.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.35M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$237.21M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$239.90M
Interest Coverage Ratio
15.37x
TTM Avg
15.37x
3Y Avg
15.37x
5Y Avg
15.37x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $249.88M | -257.92x | -119.61x | -94.79x | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.69M | N/A | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $246.02M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.54M | 0.57x | 0.57x | 0.57x | 0.57x |
| Quantum-Si incorporated (QSI)vs › | $248.27M | N/A | N/A | N/A | N/A |
| Upstream Bio, Inc. (UPB)vs › | $250.06M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | -2.74x | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $237.21M | N/A | 0.97x | 1.45x | 67.07x |
| Q32 Bio Inc. (QTTB)vs › | $239.90M | 15.37x | 15.37x | 15.37x | 15.37x |
| Invivyd, Inc. (IVVD)vs › | $238.34M | N/A | N/A | N/A | N/A |
Interest Coverage
-257.9x
Debt/Equity
0.15
Current Ratio
8.28
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-06-30 | -257.92x |
| 2023-03-31 | -79.41x |
| 2022-12-31 | -80.64x |
| 2022-09-30 | -85.09x |
| 2022-06-30 | -95.00x |
| 2022-03-31 | -119.22x |
| 2021-12-31 | -736.13x |
| 2021-09-30 | -80.21x |
| 2021-06-30 | -72.39x |
| 2021-03-31 | -57.52x |
| 2020-12-31 | -55.89x |
| 2020-09-30 | -222.56x |
